Continuous Manufacturing Back In Second Act

 
• By Bowman Cox

House tries again to promote advanced technology for the return of pharmaceutical manufacturing to the US in post-COVID-19 era.

Watch gears up close
house churns out another continuous manufacturing bill

More from Manufacturing

More from Compliance